Enerpac Tool Group Corp
EPAC NYSE Misc Industrial & Commercial Machinery & Equipment Financials FY2016βFY2025
What Enerpac Tool Group Corp does
No business description yet.
- Legal name
- ENERPAC TOOL GROUP CORP
- Fiscal year ends
- August 31, 2025
- Latest annual report
- 10-K Β· Oct 17, 2025
- Accession Β· CIK
- 0000006955-25-000030
0000006955
Revenue and margins
Enerpac Tool Group Corp had $617M of revenue in fiscal 2025, up 4.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $91.9M in fiscal 2025, 14.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Enerpac Tool Group Corp returned $70.9M to shareholders in fiscal 2025, 77% of free cash flow. The diluted share count fell 0.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Enerpac Tool Group Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $140M | $121M | $154M | $167M | $152M |
| Debt incl. finance leases | $175M | $208M | $215M | $195M | $190M |
| Net debt / EBITDA | 0.5x | 1.7x | 0.6x | 0.2x | 0.3x |
| Debt / equity | 0.4x | 0.7x | 0.7x | 0.5x | 0.4x |
| Current ratio | 2.7x | 2.2x | 2.4x | 2.9x | 2.7x |
| Quick ratio | 2.1x | 1.7x | 1.9x | 2.3x | 2.2x |
| Total assets | $820M | $757M | $763M | $777M | $828M |
| Total liabilities | $408M | $439M | $436M | $385M | $394M |
| Shareholders' equity | $412M | $319M | $327M | $392M | $434M |
| Net debt (β = net cash) | $34.6M | $87.3M | $60.3M | $27.9M | $38.4M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 9 | 7 / 9 | 4 / 9 | 6 / 9 | 7 / 9 | 6 / 9 | 8 / 9 | 7 / 9 | 6 / 9 |
| Accruals ratio | β15.5% | β10.5% | β8.5% | β23.2% | 0.4% | β2.0% | β4.6% | β4.1% | 0.6% | β2.3% |
| Altman Z'' | 4.35 | 3.86 | 6.48 | 5.83 | 6.51 | 7.05 | 6.84 | 7.63 | 5.27 | 5.25 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.1B | $617M | $641M | $655M | $493M | $529M | $571M | $598M | $590M | $617M |
| Gross profit | $403M | $260M | $283M | $293M | $217M | $243M | $265M | $295M | $301M | $312M |
| Research and development | $18.3M | $8.9M | $8.7M | $9.3M | $7.3M | $7.4M | $7.3M | $9.0M | $12.4M | $14.5M |
| Operating income | β$100M | β$84.9M | $50.2M | $47.5M | $24.2M | $51.1M | $30.7M | $83.9M | $122M | $133M |
| Pretax income | β$130M | β$118M | $19.2M | $18.7M | $7.8M | $44.0M | $24.0M | $68.9M | $106M | $121M |
| Income tax | β$25.2M | β$22.6M | $14.5M | $10.7M | $2.3M | $3.8M | $4.4M | $15.2M | $23.3M | $28.0M |
| Net income | β$105M | β$66.2M | β$21.6M | β$249M | $0.7M | $38.1M | $15.7M | $46.6M | $85.7M | $92.7M |
| Diluted EPS | β$1.78 | β$1.11 | β$0.35 | β$4.04 | $0.01 | $0.63 | $0.26 | $0.82 | $1.56 | $1.70 |
| Diluted shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $118M | $88.5M | $106M | $53.8M | β$3.2M | $54.2M | $51.7M | $77.6M | $81.3M | $111M |
| Capital expenditure | $20.2M | $17.2M | $11.0M | $14.9M | $12.1M | $12.0M | $8.4M | $9.4M | $11.4M | $19.3M |
| Free cash flow | $97.5M | $71.3M | $95.1M | $38.9M | β$15.2M | $42.2M | $43.3M | $68.2M | $69.9M | $91.9M |
| Depreciation and amortization | $47.8M | $22.9M | $20.4M | $20.2M | $20.7M | $21.6M | $19.6M | $16.3M | $13.3M | $15.7M |
| Stock-based compensation | $10.4M | $14.9M | $11.3M | $10.9M | $9.6M | $9.2M | $13.6M | $8.6M | $10.9M | $13.0M |
| Acquisitions | $81.9M | $0.0M | $23.2M | $0.0M | β$33.3M | $0.0M | $0.0M | $0.0M | $0.0M | $26.7M |
| Share buybacks | $17.1M | $0.0M | $0.0M | $22.5M | $27.5M | $0.0M | $75.1M | $57.7M | $38.4M | $68.7M |
| Dividends paid | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.3M | $2.2M | $2.2M |
| Dividends and buybacks | $19.5M | $2.4M | $2.4M | $24.9M | $29.9M | $2.4M | $77.5M | $59.9M | $40.5M | $70.9M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $180M | $230M | $250M | $211M | $152M | $140M | $121M | $154M | $167M | $152M |
| Total debt | $584M | $565M | $535M | $463M | $255M | $175M | $208M | $215M | $195M | $190M |
| Current assets | $543M | $647M | $1.0B | $730M | $341M | $357M | $342M | $356M | $372M | $376M |
| Current liabilities | $242M | $379M | $354M | $300M | $106M | $135M | $153M | $148M | $129M | $137M |
| Inventory | $131M | $144M | $72.0M | $77.2M | $69.2M | $75.3M | $83.7M | $74.8M | $72.9M | $78.8M |
| Property and equipment, net | $114M | $94.5M | $55.0M | $56.7M | $61.4M | $48.6M | $41.4M | $39.0M | $40.3M | $53.3M |
| Goodwill | $519M | $272M | $280M | $260M | $281M | $278M | $258M | $266M | $270M | $290M |
| Intangible assets | $239M | $220M | $71.7M | $52.4M | $62.4M | $54.5M | $41.5M | $37.3M | $36.1M | $46.9M |
| Total assets | $1.4B | $1.5B | $1.5B | $1.1B | $824M | $820M | $757M | $763M | $777M | $828M |
| Total liabilities | $918M | $1.0B | $927M | $823M | $465M | $408M | $439M | $436M | $385M | $394M |
| Shareholders' equity | $521M | $501M | $559M | $301M | $359M | $412M | $319M | $327M | $392M | $434M |
| Margins | ||||||||||
| Gross margin | 35.1% | 42.2% | 44.2% | 44.7% | 44.0% | 46.0% | 46.5% | 49.3% | 51.1% | 50.5% |
| Operating margin | β8.7% | β13.8% | 7.8% | 7.3% | 4.9% | 9.7% | 5.4% | 14.0% | 20.6% | 21.6% |
| EBITDA margin | β4.6% | β10.0% | 11.0% | 10.3% | 9.1% | 13.8% | 8.8% | 16.8% | 22.9% | 24.2% |
| Net margin | β9.2% | β10.7% | β3.4% | β38.1% | 0.1% | 7.2% | 2.7% | 7.8% | 14.5% | 15.0% |
| FCF margin | 8.5% | 11.6% | 14.8% | 5.9% | β3.1% | 8.0% | 7.6% | 11.4% | 11.9% | 14.9% |
| Returns | ||||||||||
| Return on capital | β8.6% | β8.0% | 3.9% | 5.6% | 3.7% | 10.5% | 6.2% | 16.9% | 22.6% | 21.7% |
| Return on capital employed | β8.4% | β7.5% | 4.4% | 5.8% | 3.4% | 7.5% | 5.1% | 13.7% | 18.8% | 19.3% |
| Return on equity | β20.2% | β13.0% | β4.1% | β57.9% | 0.2% | 9.9% | 4.3% | 14.4% | 23.9% | 22.5% |
| Return on assets | β7.3% | β4.5% | β1.4% | β19.1% | 0.1% | 4.6% | 2.0% | 6.1% | 11.1% | 11.6% |
| Return on tangible equity | β | β867.7% | β10.5% | β | 4.6% | 47.6% | 81.9% | 204.3% | 99.3% | 95.7% |
| Growth | ||||||||||
| Revenue growth | β | β46.4% | 4.0% | 2.1% | β24.7% | 7.2% | 8.1% | 4.7% | β1.5% | 4.6% |
| Net income growth | β | β | β | β | β | 5,166.5% | β58.8% | 196.8% | 84.2% | 8.2% |
| EPS growth | β | β | β | β | β | 6,200.0% | β58.7% | 215.4% | 90.2% | 9.0% |
| FCF growth | β | β26.9% | 33.4% | β59.1% | β139.1% | β | 2.7% | 57.4% | 2.5% | 31.5% |
| Share count change | β | 0.7% | 2.7% | 0.9% | β2.2% | 0.2% | β0.8% | β4.7% | β3.9% | β0.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | 4.0x | 3.7x | 2.3x | 0.5x | 1.7x | 0.6x | 0.2x | 0.3x |
| Debt / equity | 1.1x | 1.1x | 1.0x | 1.5x | 0.7x | 0.4x | 0.7x | 0.7x | 0.5x | 0.4x |
| Current ratio | 2.2x | 1.7x | 3.0x | 2.4x | 3.2x | 2.7x | 2.2x | 2.4x | 2.9x | 2.7x |
| Quick ratio | 1.7x | 1.3x | 2.8x | 2.2x | 2.6x | 2.1x | 1.7x | 1.9x | 2.3x | 2.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.8% | 2.8% | 1.7% | 2.3% | 2.4% | 2.3% | 1.5% | 1.6% | 1.9% | 3.1% |
| Stock comp / revenue | 0.9% | 2.4% | 1.8% | 1.7% | 2.0% | 1.7% | 2.4% | 1.4% | 1.9% | 2.1% |
| Payouts / FCF | 20.0% | 3.3% | 2.5% | 64.0% | β | 5.7% | 179.0% | 87.9% | 58.0% | 77.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 7.0 | 4.0 | 6.0 | 7.0 | 6.0 | 8.0 | 7.0 | 6.0 |
| Altman Z'' | 4.4 | 3.9 | 6.5 | 5.8 | 6.5 | 7.0 | 6.8 | 7.6 | 5.3 | 5.3 |
| Accruals ratio | β15.5% | β10.5% | β8.5% | β23.2% | 0.4% | β2.0% | β4.6% | β4.1% | 0.6% | β2.3% |
Source: SEC EDGAR XBRL filings (CIK 0000006955). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.